Lichen nitidus in a child receiving adalimumab for juvenile idiopathic arthritis

Indian J Dermatol Venereol Leprol. 2021 May-Jun;87(3):408-409. doi: 10.25259/IJDVL_241_19.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Juvenile / drug therapy*
  • Child
  • Humans
  • Lichen Nitidus / diagnosis*
  • Lichen Nitidus / etiology*
  • Male

Substances

  • Antirheumatic Agents
  • Adalimumab